Company information:
Optibiotix Limited (No: 07992608)
Address: INNOVATION CENTRE INNOVATION WAY, HESLINGTON, YORK, YO10 5DG
Status: Active
Incorporated: 15-Mar-2012
Accounts Next Due: 30-Sep-2024
Next Confirmation Statement Due: 14-Feb-2025
Industry Class: 72110 - Research and experimental development on biotechnology
Current Director: SHIRAZ HUSSAIN BUTT ( DOB: Oct-1986 From: Jan-2024 )
Current Director: STEPHEN PATRICK O'HARA ( DOB: Mar-1960 From: Mar-2012 )
Current Director: JAN PETER FREDIK WENNSTROM ( DOB: Aug-1957 From: Jan-2016 )
Resigned Director: DAVID ERIC EVANS ( DOB: May-1960 From: Apr-2012 To: Aug-2015 )
Resigned Director: RENE KAMMINGA ( DOB: Aug-1966 From: Mar-2021 To: Feb-2023 )
Resigned Director: FREDERIC NARBEL ( DOB: May-1984 From: Nov-2019 To: Dec-2021 )
Resigned Director: PER REHNE ( DOB: Feb-1970 From: Jun-2018 To: Feb-2019 )
Resigned Director: HEATHER ELAINE ROXBOROUGH ( From: Apr-2012 To: Sep-2013 )
Resigned Director: MARK ANDREW WYATT ( DOB: Jul-1972 From: Sep-2013 To: Jan-2016 )
Persons of Significant Control:
Optibiotix Health Plc, Innovation Centre Innovation Way, Heslington, York, YO10 5DG, England: Ownership of shares – 75% or more (Notified: 2016-04-06)